Home/Filings/4/0001567619-23-003706
4//SEC Filing

Kirn David 4

Accession 0001567619-23-003706

CIK 0001650648other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 7:56 PM ET

Size

9.4 KB

Accession

0001567619-23-003706

Insider Transaction Report

Form 4
Period: 2023-02-21
Kirn David
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2023-02-21$20.93/sh17,090$357,7181,876,509 total
  • Sale

    Common Stock

    2023-02-21$21.49/sh907$19,4911,875,602 total
  • Sale

    Common Stock

    2023-02-22$20.22/sh16,449$332,6651,859,153 total
Footnotes (4)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The transaction was executed in multiple trades in prices ranging from $20.35 to $21.305, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]The transaction was executed in multiple trades in prices ranging from $21.40 to $21.60, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F4]The transaction was executed in multiple trades in prices ranging from $19.96 to $20.71, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file

Issuer

4D Molecular Therapeutics, Inc.

CIK 0001650648

Entity typeother

Related Parties

1
  • filerCIK 0001834021

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:56 PM ET
Size
9.4 KB